{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T12:20:06Z","timestamp":1792153206187,"version":"4.4.0"},"reference-count":86,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Behavioural Brain Research"],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1016\/j.bbr.2012.03.008","type":"journal-article","created":{"date-parts":[[2012,3,16]],"date-time":"2012-03-16T21:36:41Z","timestamp":1331933801000},"page":"154-163","source":"Crossref","is-referenced-by-count":109,"title":["Repeated treatment with a low dose of reserpine as a progressive model of Parkinson's disease"],"prefix":"10.1016","volume":"231","author":[{"given":"Val\u00e9ria S.","family":"Fernandes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 R.","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anderson H.F.F.","family":"Le\u00e3o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9 M.","family":"Medeiros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thieza G.","family":"Melo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geison S.","family":"Iz\u00eddio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia","family":"Cabral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosana A.","family":"Ribeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa C.","family":"Ab\u00edlio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra M.","family":"Ribeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Regina H.","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbr.2012.03.008_bib0005","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s00441-004-0975-6","article-title":"Parkinson's disease: clinical aspects","volume":"318","author":"Klockgether","year":"2004","journal-title":"Cell Tissue Res"},{"key":"10.1016\/j.bbr.2012.03.008_bib0010","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1001\/archneur.61.12.1906","article-title":"The rate of cognitive decline in Parkinson disease","volume":"61","author":"Aarsland","year":"2004","journal-title":"Arch Neurol"},{"key":"10.1016\/j.bbr.2012.03.008_bib0015","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1136\/jnnp.64.2.178","article-title":"Neuropsychological prediction of dementia in Parkinson's disease","volume":"64","author":"Mahieux","year":"1998","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.bbr.2012.03.008_bib0020","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1136\/jnnp.2006.112367","article-title":"Cognitive impairment in Parkinson's disease","volume":"78","author":"Verbaan","year":"2007","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.bbr.2012.03.008_bib0025","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.brainres.2007.01.042","article-title":"Feedback-based versus observational classification learning in healthy aging and Parkinson's disease","volume":"1142","author":"Schmitt-Eliassen","year":"2007","journal-title":"Brain Res"},{"key":"10.1016\/j.bbr.2012.03.008_bib0030","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1093\/brain\/awf052","article-title":"Dopaminergic modulation of high-level cognition in Parkinson's disease: the role of the prefrontal cortex revealed by PET","volume":"125","author":"Cools","year":"2002","journal-title":"Brain"},{"key":"10.1016\/j.bbr.2012.03.008_bib0035","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0028-3932(01)00093-8","article-title":"Preference formation and working memory in Parkinson's disease and normal ageing","volume":"40","author":"Cox","year":"2002","journal-title":"Neuropsychologia"},{"key":"10.1016\/j.bbr.2012.03.008_bib0040","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1136\/jnnp.51.6.757","article-title":"Planning and spatial working memory in Parkinson's disease","volume":"51","author":"Morris","year":"1988","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.bbr.2012.03.008_bib0045","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1136\/jnnp.2006.093146","article-title":"Attentional deficits affect activities of daily living in dementia-associated with Parkinson's disease","volume":"77","author":"Bronnick","year":"2006","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.bbr.2012.03.008_bib0050","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/35072550","article-title":"Experimental models of Parkinson's disease","volume":"2","author":"Beal","year":"2001","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.bbr.2012.03.008_bib0055","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.nlm.2004.06.006","article-title":"Is the unilateral lesion of the left substantia nigra pars compacta sufficient to induce working memory impairment in rats","volume":"82","author":"Bellissimo","year":"2004","journal-title":"Neurobiol Learn Mem"},{"key":"10.1016\/j.bbr.2012.03.008_bib0060","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1023\/A:1020736131907","article-title":"The lesion of the rat substantia nigra pars compacta dopaminergic neurons as a model for Parkinson's disease memory disabilities","volume":"22","author":"Da Cunha","year":"2002","journal-title":"Cell Mol Neurobiol"},{"key":"10.1016\/j.bbr.2012.03.008_bib0065","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.bbr.2004.12.008","article-title":"Postural changes after lesions of the substantia nigra pars reticulata in hemiparkinsonian monkeys","volume":"160","author":"Henderson","year":"2005","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.bbr.2012.03.008_bib0070","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1016\/0028-3908(87)90110-9","article-title":"Pharmacological characteristics of tremor, rigidity and hypokinesia induced by reserpine in rat","volume":"26","author":"Colpaert","year":"1987","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bbr.2012.03.008_bib0075","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1007\/BF01291788","article-title":"Animal models of Parkinson's disease: an empirical comparison with the phenomenology of the disease in man","volume":"103","author":"Gerlach","year":"1996","journal-title":"J Neural Transm"},{"key":"10.1016\/j.bbr.2012.03.008_bib0080","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S0278-5846(01)00295-0","article-title":"Vital MABF. Behavioral effects of MK-801 on reserpine-treated mice","volume":"26","author":"Dutra","year":"2002","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.bbr.2012.03.008_bib0085","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1007\/s002130051146","article-title":"Actions of adenosine A2A receptor antagonist KW-6002 on drug-induced catalepsy and hypokinesia caused by reserpine or MPTP","volume":"147","author":"Shiozaki","year":"1999","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.bbr.2012.03.008_bib0090","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.neuropharm.2005.01.014","article-title":"Beneficial effects of vitamin C and vitamin E on reserpine-induced oral dyskinesia in rats: critical role of striatal catalase activity","volume":"48","author":"Faria","year":"2005","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bbr.2012.03.008_bib0095","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.bbr.2004.11.014","article-title":"Effects of gabaergic drugs on reserpine-induced oral dyskinesia","volume":"160","author":"Peixoto","year":"2005","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.bbr.2012.03.008_bib0100","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.ejphar.2006.02.004","article-title":"Vital MABF. Different effects of 7-nitroindazole in reserpine-induced hypolocomotion in two strains of mice","volume":"535","author":"Tadaiesky","year":"2006","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.bbr.2012.03.008_bib0105","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.brainres.2006.09.008","article-title":"Effects of reserpine on the plus-maze discriminative avoidance task: dissociation between memory and motor impairments","volume":"1122","author":"Carvalho","year":"2006","journal-title":"Brain Res"},{"key":"10.1016\/j.bbr.2012.03.008_bib0110","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1016\/j.pnpbp.2008.05.004","article-title":"Memory impairment induced by low doses of reserpine in rats: possible relationship with emotional processing deficits in Parkinson disease","volume":"32","author":"Fernandes","year":"2008","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.bbr.2012.03.008_bib0115","doi-asserted-by":"crossref","first-page":"3356","DOI":"10.1093\/brain\/awl301","article-title":"Startling facts about emotion in Parkinson's disease: blunted reactivity to aversive stimuli","volume":"129","author":"Bowers","year":"2006","journal-title":"Brain"},{"key":"10.1016\/j.bbr.2012.03.008_bib0120","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1097\/01.wnf.0000185824.57690.f0","article-title":"Dopaminergic contribution to the regulation of emotional perception","volume":"28","author":"Salgado-Pineda","year":"2005","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.bbr.2012.03.008_bib0125","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1001\/archpsyc.60.3.296","article-title":"Deep brain stimulation of the subthalamic nucleus enhances emotional processing in Parkinson disease","volume":"60","author":"Schneider","year":"2003","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.bbr.2012.03.008_bib0130","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.tins.2008.02.010","article-title":"Altered vesicular dopamine storage in Parkinson's disease: a premature demise","volume":"31","author":"Caudle","year":"2008","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.bbr.2012.03.008_bib0135","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.bbadis.2008.12.006","article-title":"Oxidative and nitrosative stress in Parkinson's disease","volume":"1792","author":"Tsang","year":"2009","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.bbr.2012.03.008_bib0140","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1001\/archpsyc.1991.01810360061009","article-title":"Oxygen radicals and neuropsychiatric illness. Some speculations","volume":"48","author":"Lohr","year":"1991","journal-title":"Arch Gen Psychiatry"},{"issue":"1","key":"10.1016\/j.bbr.2012.03.008_bib0145","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1152\/physrev.00018.2001","article-title":"Free radicals in the physiological control of cell function","volume":"82","author":"Dr\u00f6ge","year":"2002","journal-title":"Physiol Rev"},{"key":"10.1016\/j.bbr.2012.03.008_bib0150","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.pbb.2008.11.015","article-title":"Intense exercise potentiates oxidative stress in striatum of reserpine-treated animals","volume":"92","author":"Teixeira","year":"2009","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.bbr.2012.03.008_bib0155","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.neuro.2010.02.006","article-title":"The toxic influence of paraquat on hippocampus of mice: involvement of oxidative stress","volume":"31","author":"Chen","year":"2010","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.bbr.2012.03.008_bib0160","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.1749-6632.2003.tb07470.x","article-title":"Mitochondria, oxidative damage, and inflammation in Parkinson's disease","volume":"991","author":"Beal","year":"2003","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.bbr.2012.03.008_bib0165","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/S0891-5849(00)00317-8","article-title":"Mitochondrial free radical generation, oxidative stress, and aging","volume":"29","author":"Cadenas","year":"2000","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.bbr.2012.03.008_bib0170","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S0891-5849(02)00780-3","article-title":"Oxidatively modified proteins in aging and disease","volume":"32","author":"Beal","year":"2002","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.bbr.2012.03.008_bib0175","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1007\/s00702-001-0683-2","article-title":"Dopamine efflux by MPTP and hydroxyl radical generation","volume":"109","author":"Obata","year":"2002","journal-title":"J Neural Transm"},{"key":"10.1016\/j.bbr.2012.03.008_bib0180","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0891-5849(01)00758-4","article-title":"The reaction of nitric oxide with 6-hydroxydopamine: implications for Parkinson's disease","volume":"32","author":"Riob\u00f3","year":"2002","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.bbr.2012.03.008_bib0185","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1016\/j.neuroscience.2007.04.002","article-title":"Alpha-lipoic acid differently affects the reserpine-induced oxidative stress in the striatum and prefrontal cortex o rat brain","volume":"146","author":"Bilska","year":"2007","journal-title":"Neuroscience"},{"key":"10.1016\/j.bbr.2012.03.008_bib0190","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1073\/pnas.86.4.1398","article-title":"Dopamine turnover and glutathione oxidation: implications for Parkinson disease","volume":"86","author":"Spina","year":"1989","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bbr.2012.03.008_bib0195","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0165-0270(00)00289-2","article-title":"The plus-maze discriminative avoidance task: a new model to study memory\u2013anxiety interactions. Effects of chlordiazepoxide and caffeine","volume":"102","author":"Silva","year":"2000","journal-title":"J Neurosci Methods"},{"key":"10.1016\/j.bbr.2012.03.008_bib0200","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.bandc.2010.07.012","article-title":"Sex differences in aversive memory in rats: possible role of extinction and reactive emotional factors","volume":"74","author":"Ribeiro","year":"2010","journal-title":"Brain Cogn"},{"key":"10.1016\/j.bbr.2012.03.008_bib0205","doi-asserted-by":"crossref","first-page":"2910","DOI":"10.1248\/cpb.29.2910","article-title":"Micro-determination of lipoperoxide inthe mouse myocardium by thiobarbituric acid fluorophotometry","volume":"29","author":"Tanizawa","year":"1981","journal-title":"Chem Pharm Bull (Tokyo)"},{"key":"10.1016\/j.bbr.2012.03.008_bib0210","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0166-4328(99)00068-6","article-title":"Akinesia and postural abnormality after unilateral dopamine depletion","volume":"104","author":"Johnston","year":"1999","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.bbr.2012.03.008_bib0215","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0166-4328(98)00160-0","article-title":"Incomplete nigrostriatal dopaminergic cell loss and partial reductions in striatal dopamine produce akinesia, rigidity, tremor and cognitive deficits in middle-aged rats","volume":"102","author":"Lindner","year":"1999","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.bbr.2012.03.008_bib0220","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.bbr.2005.08.007","article-title":"Neglect of memory after dopaminergic lesions in monkeys","volume":"166","author":"Ridley","year":"2006","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.bbr.2012.03.008_bib0225","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1146\/annurev.neuro.26.043002.094919","article-title":"Epidemiology of neurodegeneration","volume":"26","author":"Mayeux","year":"2003","journal-title":"Annu Rev Neurosci"},{"key":"10.1016\/j.bbr.2012.03.008_bib0230","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/S0893-133X(99)00061-5","article-title":"Conditioning to injection procedures and repeated testing increase SCH 23390-induced catalepsy in mice","volume":"21","author":"Chinen","year":"1999","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bbr.2012.03.008_bib0235","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0166-4328(01)00168-1","article-title":"Motor behavioural changes after intracerebroventricular injection of 6-hydroxydopamine in the rat: an animal model of Parkinson's disease","volume":"122","author":"Diaz","year":"2001","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.bbr.2012.03.008_bib0240","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.neulet.2009.07.084","article-title":"Long-lasting resistance to haloperidol-induced catalepsy in male rats chronically treated with caffeine","volume":"463","author":"G\u00f3ngora-Alfaro","year":"2009","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.bbr.2012.03.008_bib0245","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1002\/jnr.22357","article-title":"Hexokinase II gene transfer protects against neurodegeneration in the rotenone and MPTP mouse models of Parkinson's disease","volume":"88","author":"Corona","year":"2010","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.bbr.2012.03.008_bib0250","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/S0893-133X(99)00061-5","article-title":"Context-dependent catalepsy intensification is due to classical conditioning and sensitization","volume":"14","author":"Amtage","year":"2003","journal-title":"Behav Pharmacol"},{"key":"10.1016\/j.bbr.2012.03.008_bib0255","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/00008877-200311000-00009","article-title":"Increase of spiny I activity in striatum after development of context-dependent sensitization of catalepsy in rats","volume":"354","author":"Frank","year":"2004","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.bbr.2012.03.008_bib0260","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.neulet.2003.09.020","article-title":"Behavioral sensitization to different dopamine agonists in a Parkinsonian rodent model of drug-induced dyskinesias","volume":"152","author":"Delfino","year":"2004","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.bbr.2012.03.008_bib0265","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.bbr.2003.10.009","article-title":"Comparison of bilaterally 6-OHDA- and MPTP-lesioned rats as models of the early phase of Parkinson's disease: histological, neurochemical, motor and memory alterations","volume":"148","author":"Ferro","year":"2005","journal-title":"J Neurosc Methods"},{"key":"10.1016\/j.bbr.2012.03.008_bib0270","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jneumeth.2005.04.005","article-title":"Melatonin attenuates tyrosine hydroxylase loss and hypolocomotion in MPTP-lesioned rats","volume":"594","author":"Capitelli","year":"2008","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.bbr.2012.03.008_bib0275","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ejphar.2008.07.022","article-title":"Vitamin E attenuates reserpine-induced oral dyskinesia and striatal gssg\/gsh ratio enhancement in rats","volume":"27","author":"Ab\u00edlio","year":"2003","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.bbr.2012.03.008_bib0280","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0278-5846(02)00340-8","article-title":"Important role of striatal catalase in aging- and reserpine-induced oral dyskinesia","volume":"47","author":"Ab\u00edlio","year":"2004","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bbr.2012.03.008_bib0285","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.neuropharm.2004.04.003","article-title":"Neurochemical changes associated with the persistence of spontaneous oral dyskinesia in rats following chronic reserpine treatment","volume":"558","author":"Neisewander","year":"1991","journal-title":"Brain Res"},{"key":"10.1016\/j.bbr.2012.03.008_bib0290","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0006-8993(91)90710-D","article-title":"Dose-dependent differences in the development of reserpine-induced oral dyskinesia in rats: support for a model of tardive dyskinesia","volume":"116","author":"Neisewander","year":"1994","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.bbr.2012.03.008_bib0295","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/BF02244874","article-title":"Neurotoxicity associated with neuroleptic-induced oral dyskinesias in rats. Implications for tardive dyskinesia","volume":"61","author":"Andreassen","year":"2000","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.bbr.2012.03.008_bib0300","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1093\/schbul\/23.4.567","article-title":"Neuroleptic intolerance","volume":"23","author":"Hansen","year":"1997","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.bbr.2012.03.008_bib0305","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/0091-3057(95)00164-6","article-title":"Vacuous jaw movements Induced by acute reserpine and low-dose apomorphine: possible model of Parkinsonian tremor","volume":"53","author":"Salamone","year":"1996","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.bbr.2012.03.008_bib0310","doi-asserted-by":"crossref","first-page":"S130","DOI":"10.1016\/0091-3057(95)00164-6","article-title":"Dopamine\/adenosine interactions related to locomotion and tremor in animal models: possible relevance to Parkinsonism","volume":"14","author":"Salamone","year":"2008","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.bbr.2012.03.008_bib0315","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.parkreldis.2008.04.017","article-title":"Oral dyskinesia and histopathological alterations in substantia nigra after long-term haloperidol treatment of old rats","volume":"122","author":"Andreassen","year":"2003","journal-title":"Neuroscience"},{"key":"10.1016\/j.bbr.2012.03.008_bib0320","doi-asserted-by":"crossref","first-page":"3822","DOI":"10.1016\/j.neuroscience.2003.08.058","article-title":"Vacuous jaw movements and feeding deficits in rats with ventrolateral striatal dopamine depletion: possible relation to Parkinsonian symptoms","volume":"12","author":"Jicha","year":"1991","journal-title":"J Neurosci"},{"key":"10.1016\/j.bbr.2012.03.008_bib0325","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1097\/00006123-200103000-00017","article-title":"Assessments of axial motor control during deep brain stimulation in Parkinsonian patients","volume":"48","author":"Robertson","year":"2001","journal-title":"Neurosurgery"},{"key":"10.1016\/j.bbr.2012.03.008_bib0330","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/00006123-200103000-00017","article-title":"Acute reserpine administration elicits long-term spontaneous oral dyskinesia","volume":"337","author":"Sussman","year":"1997","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.bbr.2012.03.008_bib0335","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0014-2999(97)01271-5","article-title":"Which symptoms of anxiety diminish after surgical interventions for Parkinson disease?","volume":"14","author":"Higginson","year":"2001","journal-title":"Neuropsychiatry Neuropsychol Behav Neurol"},{"key":"10.1016\/j.bbr.2012.03.008_bib0340","doi-asserted-by":"crossref","first-page":"3132","DOI":"10.1111\/j.1460-9568.2007.05580.x","article-title":"Striatal dopaminergic activity (FDOPA-PET) associated with cognitive items of depression scale (MADRS) in Parkinson's disease","volume":"25","author":"Koerts","year":"2007","journal-title":"Eur J Neurosci"},{"issue":"Suppl. 3","key":"10.1016\/j.bbr.2012.03.008_bib0345","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1460-9568.2007.05580.x","article-title":"Dementia in Parkinson's disease","volume":"248","author":"Korczyn","year":"2001","journal-title":"J Neurol"},{"key":"10.1016\/j.bbr.2012.03.008_bib0350","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1007\/s00702-004-0178-z","article-title":"Cognitive and behavioral dysfunction in Parkinson's disease: neurochemical and clinicopathogical contributions","volume":"111","author":"Zgaljardic","year":"2004","journal-title":"J Neural Transm"},{"key":"10.1016\/j.bbr.2012.03.008_bib0355","doi-asserted-by":"crossref","first-page":"13534","DOI":"10.1007\/s00702-004-0178-z","article-title":"Memory systems analyses of mnemonic disorders in aging and age-related diseases","volume":"93","author":"Gabrieli","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bbr.2012.03.008_bib0360","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1073\/pnas.93.24.13534","article-title":"The time course of spatial and object learning in Parkinson's disease","volume":"35","author":"Postle","year":"1997","journal-title":"Neuropsychologia"},{"key":"10.1016\/j.bbr.2012.03.008_bib0365","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0028-3932(97)00054-7","article-title":"Concomitant development of oral dyskinesia and memory deficits in reserpine-treated male and female mice","volume":"132","author":"Silva","year":"2002","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.bbr.2012.03.008_bib0370","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0166-4328(01)00409-0","article-title":"Dissociation of the effects of ethanol on memory, anxiety, and motor behavior in mice tested in the plus-maze discriminative avoidance task","volume":"192","author":"Kameda","year":"2007","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.bbr.2012.03.008_bib0375","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s00213-006-0684-9","article-title":"Effects of amphetamine on the plus-maze discriminative avoidance task in mice","volume":"160","author":"Silva","year":"2002","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.bbr.2012.03.008_bib0380","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1007\/s00213-001-0948-3","article-title":"Amnestic effect of cocaine after the termination of its stimulant action","volume":"34","author":"Niigaki","year":"2010","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.bbr.2012.03.008_bib0385","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/j.pnpbp.2009.11.010","article-title":"Dopaminergic modulation of emotional memory in Parkinson's disease","volume":"115","author":"Halbig","year":"2008","journal-title":"J Neural Transm"},{"key":"10.1016\/j.bbr.2012.03.008_bib0390","doi-asserted-by":"crossref","first-page":"6853","DOI":"10.1007\/s00702-008-0061-4","article-title":"Relationship between the appearance of symptoms and the level of nigrostriatal degeneration in a progressive 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned macaque model of Parkinson's disease","volume":"21","author":"Bezard","year":"2001","journal-title":"J Neurosci"},{"key":"10.1016\/j.bbr.2012.03.008_bib0395","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0301-0082(98)00006-9","article-title":"Compensatory mechanisms in experimental and human Parkinsonism: towards a dynamic approach","volume":"55","author":"Bezard","year":"1998","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.bbr.2012.03.008_bib0400","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1016\/S0301-0082(98)00006-9","article-title":"Changes in striatal dopamine neurotransmission assessed with microdialysis following recovery from a bilateral 6-OHDA lesion: variation as a function of lesion size","volume":"10","author":"Castaneda","year":"1990","journal-title":"J Neurosci"},{"key":"10.1016\/j.bbr.2012.03.008_bib0405","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/j.biopsych.2006.03.004","article-title":"Molecular imaging of the dopaminergic system and its association with human cognitive function","volume":"59","author":"Cropley","year":"2006","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.bbr.2012.03.008_bib0410","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.biopsych.2006.03.004","article-title":"Long-term l-DOPA treatment causes indiscriminate increase in dopamine levels at the cost of serotonin synthesis in discrete brain regions of rats","volume":"27","author":"Borah","year":"2007","journal-title":"Cell Mol Neurobiol"},{"key":"10.1016\/j.bbr.2012.03.008_bib0415","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s10571-007-9213-6","article-title":"The role of striatal metabotropic glutamate receptors in Parkinson's disease","volume":"23","author":"Ossowska","year":"2002","journal-title":"Amino Acids"},{"key":"10.1016\/j.bbr.2012.03.008_bib0420","doi-asserted-by":"crossref","first-page":"8138","DOI":"10.1007\/s00726-001-0128-0","article-title":"Reduced vesicular storage of dopamine causes progressive nigrostriatal neurodegeneration","volume":"27","author":"Caudle","year":"2007","journal-title":"J Neurosci"},{"key":"10.1016\/j.bbr.2012.03.008_bib0425","doi-asserted-by":"crossref","first-page":"8103","DOI":"10.1523\/JNEUROSCI.0319-07.2007","article-title":"Nonmotor symptoms of Parkinson's disease revealed in an animal model with reduced monoamine storage capacity","volume":"29","author":"Taylor","year":"2009","journal-title":"J Neurosci"},{"key":"10.1016\/j.bbr.2012.03.008_bib0430","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1523\/JNEUROSCI.1495-09.2009","article-title":"Immunochemical analysis of vesicular monoamine transporter (VMAT2) protein in Parkinson's disease","volume":"156","author":"Miller","year":"1999","journal-title":"Exp Neurol"}],"container-title":["Behavioural Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432812001878?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432812001878?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,21]],"date-time":"2024-04-21T11:32:17Z","timestamp":1713699137000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166432812001878"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5]]},"references-count":86,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["S0166432812001878"],"URL":"https:\/\/doi.org\/10.1016\/j.bbr.2012.03.008","relation":{},"ISSN":["0166-4328"],"issn-type":[{"value":"0166-4328","type":"print"}],"subject":[],"published":{"date-parts":[[2012,5]]}}}